We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...

Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

The announcement by US President Donald Trump that the USA will withdraw from WHO1 will leave both a large financial gap and ...

Against all odds, in a victory of data over opinion, and after the determined work of the Health and Social Care Select ...

Artificial intelligence (AI) for mammography is an early exemplar of the integration of AI systems into clinical pathways and ...

We would like to thank Nikolas Ruffer and Martin Krusche for their considered Correspondence; their letter raised an important point regarding the nomenclature used in our case report. The authors ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Afghanistan's de facto authorities have made the alarming decision to ban women from studying nursing and midwifery.1 This policy, along with the broader ban on girls completing education beyond grade ...

The monkeypox virus is causing concurrent outbreaks of mpox in Africa, with more and more frequent exportations outside the ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...